At The Uromigos Live & Unplugged event, Chandler Park, MD, Norton Healthcare, shares how PSMAfore builds upon the VISION study and why it may be too soon to tell if there is meaningful survival benefit to gain from Lu-177 PSMA-617 prior to chemotherapy.
Dr. Park was particularly impressed by the “profound” experience offered to all panelists and attendees during the Rising Stars event.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.